glp-1 and substance use disorder medications get at the heart of addiction: study – WashU Medicine Now, new research suggests that

Since both diabetes and obesity are risk factors for PDAC, there is a potential role for the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) for PDAC risk reduction

Electrolyte drinks may also be beneficial, especially if youre experiencing digestive side effects from your medication

Rybelsus is approved for type 2 diabetes, and the Wegovy pill was approved in December 2025 for weight loss at a higher dose

Obesity, inflammation, and the potential application of pharmaco-nutrition

Support post-GLP-1 so you adjust to your new baseline and your results last

The application of engineered cell strains with special plasmid vectors that encode fusion proteins helps to develop targeted exosome-based delivery systems by achieving amenable membrane modifications and desirable attributes especially when targeting a specific cell type ( Application of Exosomes Providing a Novel View for Ferroptosis-Based Cancer Treatment Modified exosomes can be selectively used to deliver drugs to specific cells and present advantages, such as high effectiveness and reduced toxicity